Literature DB >> 15288985

The giant fornix syndrome: an unrecognized cause of chronic, relapsing, grossly purulent conjunctivitis.

Geoffrey E Rose1.   

Abstract

AIM: To describe a group of elderly patients presenting with chronic, relapsing, copiously purulent conjunctivitis, in which the condition was often perpetuated by the sequestration of a large number of bacteria on a protein coagulum lodged in the recesses of a large upper conjunctival fornix. PATIENTS AND METHODS: Retrospective review of a noncomparative case series, drawn from patients attending the lacrimal clinic at Moorfields Eye Hospital. OUTCOME MEASURES: Characterization of this unrecognized syndrome and its response to treatment.
RESULTS: Twelve patients (10 female) presented between the ages of 77 and 93 years (mean, 85; median, 86) with a history of chronic relapsing bacterial conjunctivitis affecting, with 2 exceptions, just one eye. All had experienced multiple episodes of markedly purulent conjunctivitis and chronic ocular discharge for between 8 and 48 months (mean, 23.5; median, 24) before referral, and the patients had received multiple courses of treatment. Three had successful external dacryocystorhinostomy (for nasolacrimal duct occlusion) before the final diagnosis of giant fornix syndrome was made, 9 had developed corneal vascularization and scarring before referral, and 5 had suffered prior spontaneous corneal perforation or thinning. All patients had deep upper conjunctival fornices in association with the changes of age-related dehiscence of the levator muscle aponeurosis. Copious amounts of thick, purulent debris and a yellow coagulum were lodged in the depths of the upper fornix-this debris universally culturing Staphylococcus aureus. The condition settled rapidly on appropriate systemic antibiotics (ciprofloxacin or ofloxacin), intensive topical antibiotics, and high-dose, high-potency steroids; some patients required repeated treatment or needed to continue the use of a single drop of a combined steroid-antibiotic to prevent relapse.
CONCLUSION: The capacious upper fornix of the elderly may harbor a coagulum colonized by S. aureus, leading to chronic conjunctivitis that may lead to severe sight impairment due to toxic keratopathy and secondary corneal vascularization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288985     DOI: 10.1016/j.ophtha.2004.01.037

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment.

Authors:  G Jutley; D Carpenter; S Hau; D Booth; H A Jasim; E Tay; C Daniel; V Saw
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

2.  An alternative method for upper and lower conjunctival fornix measurement.

Authors:  R Peden; L Hughes; M Wright
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

3.  Management of giant fornix syndrome with irrigation with povidone-iodine.

Authors:  Rushmia Karim; Niraj Mandal; Steve Tuft
Journal:  BMJ Case Rep       Date:  2018-10-12

4.  Successful Treatment with Chronic Conjunctivitis: Removal of Tarsoconjunctival Crypt.

Authors:  Yun Hyup Na; Se Jung Seo; Joo Youn Shin; Jong Hyun Lee; Jin Hyoung Kim; Do Hyung Lee
Journal:  Korean J Ophthalmol       Date:  2016-07-21

5.  Systemic Minocycline Treatment of Methicillin-resistant Staphylococcus aureus in Giant Fornix Syndrome.

Authors:  Kang Won Lee; Ji Won Jung
Journal:  Korean J Ophthalmol       Date:  2016-09-29

6.  Discharge and infection in retinoblastoma post-enucleation sockets.

Authors:  Daphne L Mourits; Dyonne T Hartong; Andries E Budding; Machteld I Bosscha; H Stevie Tan; Annette C Moll
Journal:  Clin Ophthalmol       Date:  2017-03-01

7.  Use of hyaluronic acid gel filler to improve contact lens wear in patients with deep sunken superior sulcus.

Authors:  Mehryar Ray Taban; Neda Shamie
Journal:  J Curr Ophthalmol       Date:  2018-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.